MT2017-45: CAR-T Cell Therapy for Heme Malignancies
Clinical trial NCT03642626 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03642626
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-18
- Primary completion
- 2024-02-09
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.